28 August 2023>: Clinical Research
Impaired Renal Vein Flow in Atrial Fibrillation: A Potential Risk for Renal Dysfunction
Bayram Öztürk 1ABEF , Kemal Göçer 2ADE* , Ekrem Aksu 2ACD , Kamil Doğan 3ABEDOI: 10.12659/MSM.941435
Med Sci Monit 2023; 29:e941435
Table 3 Laboratory parameters between sinus rhythm and atrial fibrillation groups.
Laboratory parameters | Atrial fibrillation (I=34) | Sinus rhythm (n=34) | p value |
---|---|---|---|
Creatine, mg/dl | 0.97 ± 0.35 | 0.83 ± 0.34 | 0.101 |
Blood urea nitrogen, mg/dl | 20.04 ± 11.06 | 14.12 ± 6.44 | |
Sodium, mmol/L | 140.26 ± 3.68 | 140 ± 3.42 | 0.830 |
Potassium, mmol/L | 4.50 ± 0.47 | 4.32 ± 0.39 | 0.122 |
Aspartate aminotransferase (UI/L) | 22.44 ± 15.46 | 18.52 ± 9.68 | 0.226 |
Alanine aminotransferase (UI/L) | 21.46 ± 18.56 | 21.42 ± 9.62 | 0.891 |
Albumin, gr/dL | 41.90 ± 3.42 | 44.61 ± 2.85 | |
Pro-brain natriuretic peptide, ng/L | 962.44 ± 408 | 368.44± 42.24 | |
White blood cell count, 10/L | 8.52 ± 2.54 | 7.88 ± 2.26 | 0.255 |
Hemoglobin, g/dL | 13.48 ± 2.24 | 14.02 ± 1.64 | 0.052 |
Platelet count (10/mL) | 249.54 ± 69.62 | 272.78 ± 69.82 | 0.178 |
p |